NTPDase1(CD39) was played a key role in turning an ATP-mediated immune-stimulating into an adenosine-mediated immunosuppressant tumor microenvironment (TME) involving the coordinated control of inflammatory responses and tumor-associated antigen-specifific T cell immunity [52]. Here, ENTPD1 is linked to neoplasm.